Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
987882 | Value in Health | 2010 | 9 Pages |
Abstract
In New Zealand, medicines are heavily subsidized across therapy groups, but those uniquely subsidized were older entities. In Finland, more “newer” medicines are subsidized and available, but the level and coverage of subsidy is lower and thus, the patient cost burden is higher. The cost containment policies adopted seem to affect patients' access to medicines mainly by availability in New Zealand and by affordability in Finland.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Katri MSc (Pharm), Rajan BPharm BSc (Microbiology), June BPharm (Hons), Mpharm, PhD, David MBBS, PhD, Pauline BA, MA, PhD,